POSC283 Number Needed to Treat and Incremental Costs per Responder for Biologics and Targeted Synthetic Drugs in Adult Patients with Active Psoriatic Arthritis in the Russian Federation

Abstract

Psoriatic arthritis (PsA) is an autoimmune disease – a rare form of inflammatory arthritis with variety of symptoms, which imposes a considerable economic burden to patients and society. A growing range of new medicines is extremely helpful in controlling condition. However, the costs of therapy remain substantial.